drugset / Trial / NCT04132479

The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar

NCT04132479

RandomizedParallel-groupOpen-labelTreatment

Summary

This study aims to: 1. Determine the prevalence of Helicobacter infection in Myanmar (this would be the largest ever series in the country) 2. Determine the clinical and epidemiological associations of Helicobacter infection in Myanmar 3. Determine the utility of stool antigen testing to diagnose the infection and confirm eradication 4. Compare the relative efficacies of concomitant and sequential therapy 5. Determine the relative efficacies of first, second and third line therapies in Myanmar in 2018

Timeline

Start
2018-01-01
Primary completion
2018-12-31
Completion
2019-04-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 1000 mg Oral
Comparator Clarithromycin Small molecule 1000 mg Oral
Comparator Rabeprazole Small molecule 20 mg Oral
Comparator tinidazole Small molecule 500 mg Oral